About Cellcolabs
Cellcolabs is a company based in Solna (Sweden) founded in 2021.. Cellcolabs has raised $24.99 million across 3 funding rounds from investors including Fredrik Österberg, Jens von Bahr and unknown. Cellcolabs offers products and services including Mesenchymal Stromal Cells. Cellcolabs operates in a competitive market with competitors including Cryo-Cell, China Cord Blood Corporation, BioLife Plasma Services, FamilyCord and Lazo de Vida, among others.
- Headquarter Solna, Sweden
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$24.99 M (USD)
in 3 rounds
-
Latest Funding Round
$12 M (USD), Series A
Oct 26, 2025
-
Investors
unknown
& 5 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Cellcolabs
Cellcolabs offers a comprehensive portfolio of products and services, including Mesenchymal Stromal Cells. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
High-quality cells produced for research and clinical applications.
Unlock access to complete
Funding Insights of Cellcolabs
Cellcolabs has successfully raised a total of $24.99M across 3 strategic funding rounds. The most recent funding activity was a Series A round of $12 million completed in October 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 3
- Last Round Series A — $12.0M
-
First Round
First Round
(02 Jun 2023)
- Investors Count 6
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct, 2025 | Amount | Series A - Cellcolabs | Valuation | unknown |
|
| Mar, 2024 | Amount | Angel Round - Cellcolabs | Valuation |
investors |
|
| Jun, 2023 | Amount | Seed - Cellcolabs | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Cellcolabs
Cellcolabs has secured backing from 6 investors, including angel and venture fund investors. Prominent investors backing the company include Fredrik Österberg, Jens von Bahr and unknown. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Founded Year | Domain | Location | |
|
FÖ
Fredrik Österberg |
-
|
Founded Year | Domain | Location |
|
JV
Jens von Bahr |
Co-founder of Evolution Gaming, active angel investor in Indian startups
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Cellcolabs
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Cellcolabs
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Cellcolabs Comparisons
Competitors of Cellcolabs
Cellcolabs operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Cryo-Cell, China Cord Blood Corporation, BioLife Plasma Services, FamilyCord and Lazo de Vida, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Cord blood and tissue stem cells are stored for preservation.
|
|
| domain | founded_year | HQ Location |
Umbilical cord blood stem cell banking services are provided.
|
|
| domain | founded_year | HQ Location |
BioLife Plasma Services collects high-quality plasma and processes it into lifesaving therapies.
|
|
| domain | founded_year | HQ Location |
Provides comprehensive stem cell storage services for individuals.
|
|
| domain | founded_year | HQ Location |
Provider of stem cell banking services
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Cellcolabs
Frequently Asked Questions about Cellcolabs
When was Cellcolabs founded?
Cellcolabs was founded in 2021 and raised its 1st funding round 2 years after it was founded.
Where is Cellcolabs located?
Cellcolabs is headquartered in Solna, Sweden.
Who is the current CEO of Cellcolabs?
Mattias Bernow is the current CEO of Cellcolabs.
Is Cellcolabs a funded company?
Cellcolabs is a funded company, having raised a total of $24.99M across 3 funding rounds to date. The company's 1st funding round was a Seed of $4.29M, raised on Jun 02, 2023.
What does Cellcolabs do?
Cellcolabs was founded in 2021 and is based in Solna, Sweden. Stem cell banking services are offered to support the healthcare sector, with a focus on storage and preservation for medical applications. Operations are conducted in the biotechnology domain, emphasizing reliable solutions for stem cell management. The company is led by CEO Mattias Bernow, ensuring strategic oversight in this specialized field.
Who are the top competitors of Cellcolabs?
Cellcolabs's top competitors include Cryo-Cell, China Cord Blood Corporation and Lazo de Vida.
What products or services does Cellcolabs offer?
Cellcolabs offers Mesenchymal Stromal Cells.
Who are Cellcolabs's investors?
Cellcolabs has 6 investors. Key investors include Fredrik Österberg, Jens von Bahr, unknown, Norrsken Foundation, and Johannes Schildt.